Genetic test can identify how patients with triple negative early-stage breast cancer will respond to immunotherapy

  • Post author:
  • Post category:uncategorized

Researchers have developed a genetic test that can identify how patients with triple negative early-stage breast cancer will respond to immunotherapy drugs.